These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8616529)

  • 41. Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours.
    Stridsberg M; Eriksson B; Lundqvist G; Skogseid B; Wilander E; Oberg K
    Regul Pept; 1995 Jan; 55(2):119-31. PubMed ID: 7754100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Failure of islet amyloid polypeptide to inhibit basal and glucose-stimulated insulin secretion in model experiments in mice and rats.
    Pettersson M; Ahrén B
    Acta Physiol Scand; 1990 Mar; 138(3):389-94. PubMed ID: 2183542
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of insulin treatment on circulating islet amyloid polypeptide in patients with NIDDM.
    Lindström T; Leckström A; Westermark P; Arnqvist HJ
    Diabet Med; 1997 Jun; 14(6):472-6. PubMed ID: 9212313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effect of insulin treatment on islet amyloid polypeptide (amylin) and insulin gene expression in streptozotocin-induced diabetes in rats.
    Mulder H; Ahrén B; Sundler F
    J Endocrinol; 1997 Mar; 152(3):495-501. PubMed ID: 9071971
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High plasma amylin/islet amyloid polypeptide levels in patients with residual medullary thyroid carcinoma after total thyroidectomy.
    Alevizaki M; Grigorakis SI; Tseleni-Balafouta S; Alevizaki CC; Philippou G; Anastasiou E; Souvatzoglou A
    Eur J Endocrinol; 2001 Nov; 145(5):585-9. PubMed ID: 11720876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of human islet amyloid polypeptide/amylin impairs insulin secretion in mouse pancreatic beta cells.
    Tokuyama T; Yagui K; Yamaguchi T; Huang CI; Kuramoto N; Shimada F; Miyazaki J; Horie H; Saito Y; Makino H; Kanatsuka A
    Metabolism; 1997 Sep; 46(9):1044-51. PubMed ID: 9284894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells.
    Kahn SE; D'Alessio DA; Schwartz MW; Fujimoto WY; Ensinck JW; Taborsky GJ; Porte D
    Diabetes; 1990 May; 39(5):634-8. PubMed ID: 2185112
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of long-term infusion of anorexic concentrations of islet amyloid polypeptide on neurotransmitters and neuropeptides in rat brain.
    Arnelo U; Herrington MK; Theodorsson E; Adrian TE; Reidelberger R; Larsson J; Marcusson J; Strömmer L; Ding X; Permert J
    Brain Res; 2000 Dec; 887(2):391-8. PubMed ID: 11134629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Islet amyloid polypeptide (IAPP) secretion from pancreatic islets isolated from non-obese diabetic (NOD) mice.
    Karlsson E; Stridsberg M; Sandler S
    Regul Pept; 1996 May; 63(1):39-45. PubMed ID: 8795087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets.
    Wang ZL; Bennet WM; Ghatei MA; Byfield PG; Smith DM; Bloom SR
    Diabetes; 1993 Feb; 42(2):330-5. PubMed ID: 8425669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative immunohistochemical analysis of islet amyloid polypeptide (IAPP) in normal, impaired glucose tolerant, and diabetic cats.
    Ma Z; Westermark GT; Johnson KH; O'Brien TD; Westermark P
    Amyloid; 1998 Dec; 5(4):255-61. PubMed ID: 10036583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism.
    Tassone F; Procopio M; Gianotti L; Visconti G; Pia A; Terzolo M; Borretta G
    Diabet Med; 2009 Oct; 26(10):968-73. PubMed ID: 19900227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Islet amyloid polypeptide/amylin messenger RNA and protein expression in human insulinomas in relation to amyloid formation.
    van Hulst KL; Oosterwijk C; Born W; Vroom TM; Nieuwenhuis MG; Blankenstein MA; Lips CJ; Fischer JA; Höppener JW
    Eur J Endocrinol; 1999 Jan; 140(1):69-78. PubMed ID: 10037255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal elimination of islet amyloid polypeptide.
    Leckström A; Björklund K; Permert J; Larsson R; Westermark P
    Biochem Biophys Res Commun; 1997 Oct; 239(1):265-8. PubMed ID: 9345307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of islet amyloid polypeptide secretion in insulin-resistant humans.
    Kautzky-Willer A; Thomaseth K; Pacini G; Clodi M; Ludvik B; Streli C; Waldhäusl W; Prager R
    Diabetologia; 1994 Feb; 37(2):188-94. PubMed ID: 8163054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus.
    O'Brien TD; Butler PC; Westermark P; Johnson KH
    Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse.
    D'Alessio DA; Verchere CB; Kahn SE; Hoagland V; Baskin DG; Palmiter RD; Ensinck JW
    Diabetes; 1994 Dec; 43(12):1457-61. PubMed ID: 7958499
    [TBL] [Abstract][Full Text] [Related]  

  • 58. beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes.
    Andrikopoulos S; Verchere CB; Terauchi Y; Kadowaki T; Kahn SE
    Diabetes; 2000 Dec; 49(12):2056-62. PubMed ID: 11118007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of glucose tolerance, insulin secretion, and insulin action in patients with primary hyperparathyroidism before and after surgery.
    Prager R; Schernthaner G; Niederle B; Roka R
    Calcif Tissue Int; 1990 Jan; 46(1):1-4. PubMed ID: 2104769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Failure to establish islet amyloid polypeptide (amylin) as a circulating beta cell inhibiting hormone in man.
    Bretherton-Watt D; Gilbey SG; Ghatei MA; Beacham J; Bloom SR
    Diabetologia; 1990 Feb; 33(2):115-7. PubMed ID: 2328845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.